158 related articles for article (PubMed ID: 37436560)
21. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma.
Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J
Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975
[TBL] [Abstract][Full Text] [Related]
22. Identification of iron metabolism-related genes as prognostic indicators for papillary thyroid carcinoma: a retrospective study.
Jin T; Ge L; Chen J; Wang W; Zhang L; Ge M
PeerJ; 2023; 11():e15592. PubMed ID: 37361050
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
Biomed Res Int; 2022; 2022():2056913. PubMed ID: 35937391
[TBL] [Abstract][Full Text] [Related]
24. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
25. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
[TBL] [Abstract][Full Text] [Related]
26. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma.
Shi J; Wu P; Sheng L; Sun W; Zhang H
Cancer Cell Int; 2021 Dec; 21(1):669. PubMed ID: 34906147
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
[TBL] [Abstract][Full Text] [Related]
28. Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA.
Cai Y; Wu S; Jia Y; Pan X; Li C
J Immunol Res; 2022; 2022():1249290. PubMed ID: 35528617
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics analysis based on ferroptosis-related lncRNAs: construction of a clinical prognostic model for nasopharyngeal carcinoma and correlation analysis.
Dai Z; Zhong Y
Transl Cancer Res; 2022 Jun; 11(6):1665-1677. PubMed ID: 35836516
[TBL] [Abstract][Full Text] [Related]
30. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
Wei J; Zeng Y; Gao X; Liu T
BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract][Full Text] [Related]
32. Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer.
Xia Y; Jiang X; Huang Y; Liu Q; Huang Y; Zhang B; Mei Z; Xu D; Shi Y; Tu W
Front Endocrinol (Lausanne); 2022; 13():895428. PubMed ID: 35757399
[TBL] [Abstract][Full Text] [Related]
33. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation.
Xiang X; Guo Y; Chen Z; Zhang F; Huang J; Qin Y
Medicine (Baltimore); 2022 Dec; 101(51):e32558. PubMed ID: 36595859
[TBL] [Abstract][Full Text] [Related]
34. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
Front Immunol; 2021; 12():783362. PubMed ID: 35154072
[TBL] [Abstract][Full Text] [Related]
35. Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting 131I Uptake and Mortality in Papillary Thyroid Cancer Patients with Lung Metastases.
Qiu ZL; Shen CT; Sun ZK; Wei WJ; Zhang XY; Song HJ; Luo QY
Cell Physiol Biochem; 2016; 40(6):1377-1390. PubMed ID: 27997908
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of lncRNA-mediated ceRNA network in papillary thyroid cancer.
Sun Y; Dai WR; Xia N
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10003-10014. PubMed ID: 33090405
[TBL] [Abstract][Full Text] [Related]
37. Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma.
Qiu L; Tao A; Liu F; Ge X; Li C
BMC Genom Data; 2022 Nov; 23(1):80. PubMed ID: 36384476
[TBL] [Abstract][Full Text] [Related]
38. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
39. Identification of prognostic signature with seven LncRNAs for papillary thyroid carcinoma.
Guo C; Li H; Pan N; Xu S; Zeng Q; Zhou B; Wang J
Adv Med Sci; 2022 Mar; 67(1):103-113. PubMed ID: 35121283
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma.
Hou S; Zhuang YY; Lin QY; Chen Z; Zhao HG; Zhang L; Lin CH
Exp Mol Pathol; 2021 Aug; 121():104658. PubMed ID: 34102210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
